Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation

B Long, BM Carius, S Chavez, SY Liang… - The American journal of …, 2022 - Elsevier
Introduction Coronavirus disease of 2019 (COVID-19) has resulted in millions of cases
worldwide. As the pandemic has progressed, the understanding of this disease has evolved …

Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation. A meta-analysis

ZJ Lim, A Subramaniam, M Ponnapa Reddy… - American journal of …, 2021 - atsjournals.org
Rationale: Initial reports of case fatality rates (CFRs) among adults with coronavirus disease
(COVID-19) receiving invasive mechanical ventilation (IMV) are highly variable. Objectives …

Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19

N Rosenthal, Z Cao, J Gundrum, J Sianis… - JAMA network …, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) has infected more than 8.1 million US
residents and killed more than 221 000. There is a dearth of research on epidemiology and …

Substantial underestimation of SARS-CoV-2 infection in the United States

SL Wu, AN Mertens, YS Crider, A Nguyen… - Nature …, 2020 - nature.com
Accurate estimates of the burden of SARS-CoV-2 infection are critical to informing pandemic
response. Confirmed COVID-19 case counts in the US do not capture the total burden of the …

Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis

AA Agyeman, KL Chin, CB Landersdorfer, D Liew… - Mayo Clinic …, 2020 - Elsevier
Objective To estimate the prevalence of olfactory and gustatory dysfunctions (OGDs) among
patients infected with novel coronavirus disease 2019 (COVID-19). Methods A systematic …

Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID‐19): a meta‐analysis of 27,492 patients

J Saniasiaya, MA Islam, B Abdullah - The Laryngoscope, 2021 - Wiley Online Library
Objectives/Hypothesis Olfactory dysfunction has been observed as one of the clinical
manifestations in COVID‐19 patients. We aimed to conduct a systematic review and meta …

COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up

A Tajbakhsh, SM Gheibi Hayat… - Expert review of anti …, 2021 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) has the characteristics of
high transmission, diverse clinical manifestations, and a long incubation period. In addition …

Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis

S Ramasamy, S Subbian - Clinical microbiology reviews, 2021 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19), a rapidly evolving pandemic worldwide with at least 68 million …

Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis

G Corona, A Pizzocaro, W Vena, G Rastrelli… - Reviews in Endocrine …, 2021 - Springer
The presence of SARS-CoV-2 was officially documented in Europe at the end of February
2020. Despite many observations, the real impact of COVID-19 in the European Union (EU) …

Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies …

K Dorjee, H Kim, E Bonomo, R Dolma - PloS one, 2020 - journals.plos.org
Introduction Progression of COVID-19 to severe disease and death is insufficiently
understood. Objective Summarize the prevalence of risk factors and adverse outcomes and …